• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体部立体定向放疗治疗食管癌寡转移肺部病灶:结果和预后因素。

Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors.

机构信息

Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan

Department of Radiology, Toho University Omori Medical Center, Tokyo, Japan.

出版信息

Anticancer Res. 2020 Apr;40(4):2065-2072. doi: 10.21873/anticanres.14164.

DOI:10.21873/anticanres.14164
PMID:32234898
Abstract

BACKGROUND/AIM: The aim of this multi-center retrospective study was to investigate the results of stereotactic body radiotherapy (SBRT) for pulmonary oligometastases from esophageal cancer.

PATIENTS AND METHODS

Oligometastases from the esophagus were identified from a dataset of a Japanese survey. The Kaplan-Meier method and Cox regression were applied to perform analyses.

RESULTS

A total of 114 patients with 132 pulmonary oligometastases were collected. The 3-year local control rate, freedom from further metastasis (FFFM) rate and overall survival (OS) rate were 70.2%, 25.3% and 37.5%, respectively. Performance status (PS) (PS 1 vs. PS 0, p<0.01), disease-free interval (p=0.03) and history of local therapy for metastasis (p=0.01) had significant relationships with FFFM and only PS was an independent prognostic factor for OS (PS 1 vs. PS 0, p=0.02; PS 2-3 vs. PS 0, p=0.04).

CONCLUSION

SBRT for pulmonary oligometastases from esophageal cancer provided good local control and survival.

摘要

背景/目的:本多中心回顾性研究旨在探讨立体定向体部放疗(SBRT)治疗食管癌肺寡转移的疗效。

患者与方法

从日本调查数据集确定食管寡转移灶。采用Kaplan-Meier 法和 Cox 回归进行分析。

结果

共收集 114 例 132 个肺寡转移灶患者。3 年局部控制率、无进一步转移(FFFM)率和总生存率(OS)率分别为 70.2%、25.3%和 37.5%。体力状态(PS)(PS1 与 PS0,p<0.01)、无疾病间期(p=0.03)和转移灶局部治疗史(p=0.01)与 FFFM 显著相关,只有 PS 是 OS 的独立预后因素(PS1 与 PS0,p=0.02;PS2-3 与 PS0,p=0.04)。

结论

SBRT 治疗食管癌肺寡转移灶可获得良好的局部控制和生存。

相似文献

1
Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Esophageal Cancer: Results and Prognostic Factors.体部立体定向放疗治疗食管癌寡转移肺部病灶:结果和预后因素。
Anticancer Res. 2020 Apr;40(4):2065-2072. doi: 10.21873/anticanres.14164.
2
Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma.立体定向体部放疗治疗结直肠腺癌肺寡转移灶的局部控制和生存分析。
J Radiat Res. 2020 Nov 16;61(6):935-944. doi: 10.1093/jrr/rraa071.
3
Survival and prognostic factors of pulmonary oligometastases treated with stereotactic body radiotherapy.立体定向体部放疗治疗肺寡转移瘤的生存和预后因素。
Acta Oncol. 2019 Jan;58(1):74-80. doi: 10.1080/0284186X.2018.1521986. Epub 2018 Oct 3.
4
Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients.立体定向体部放疗治疗肺寡转移瘤:一项全国范围内 1378 例患者的调查。
Anticancer Res. 2020 Jan;40(1):393-399. doi: 10.21873/anticanres.13965.
5
Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival.立体定向体部放疗后寡转移肺部局部控制的分析及局部控制对生存的影响。
BMC Cancer. 2020 Oct 14;20(1):997. doi: 10.1186/s12885-020-07514-9.
6
Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.寡转移瘤的肺部立体定向放射治疗:寡复发与同步寡转移瘤的比较
Jpn J Clin Oncol. 2016 Jul;46(7):687-91. doi: 10.1093/jjco/hyw047. Epub 2016 May 9.
7
Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.寡复发预示着接受立体定向放射外科或立体定向放射治疗的非小细胞肺癌脑转移患者仅脑内寡转移灶的预后良好:一项对61例患者的多机构研究。
BMC Cancer. 2016 Aug 19;16(1):659. doi: 10.1186/s12885-016-2680-8.
8
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".立体定向体部放疗(SBRT)治疗医学上无法手术切除的肺转移瘤——德国“立体定向放疗”工作组的汇总分析
Lung Cancer. 2016 Jul;97:51-8. doi: 10.1016/j.lungcan.2016.04.012. Epub 2016 Apr 26.
9
Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation.立体定向体部放疗治疗肺寡转移瘤的结果:一项双机构合作研究。
Anticancer Res. 2015 Sep;35(9):4903-8.
10
Factors related to primary cancer death and non-primary cancer death in patients treated with stereotactic body radiotherapy for pulmonary oligometastases.立体定向体部放疗治疗肺寡转移瘤患者的原发性癌症死亡和非原发性癌症死亡相关因素。
Cancer Med. 2020 Dec;9(23):8902-8911. doi: 10.1002/cam4.3508. Epub 2020 Oct 6.

引用本文的文献

1
Stereotactic Body Radiation Therapy for Oligometastatic Recurrent Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study From a Single Tertiary Center.立体定向体部放射治疗寡转移复发性食管鳞状细胞癌:来自单一三级中心的回顾性队列研究
Cancer Rep (Hoboken). 2025 Jun;8(6):e70248. doi: 10.1002/cnr2.70248.
2
Stereotactic body radiotherapy takes on Lung Oligometastases: Latest breakthroughs.立体定向体部放射治疗在肺寡转移瘤中的应用:最新突破
Precis Radiat Oncol. 2024 May 9;8(2):85-91. doi: 10.1002/pro6.1226. eCollection 2024 Jun.
3
Salvage Chemoradiotherapy for Loco-Regional Recurrence of Esophageal Squamous Cell Carcinoma After Esophagectomy.
食管癌切除术后局部区域复发的挽救性放化疗用于食管鳞状细胞癌
J Clin Med. 2025 Feb 25;14(5):1540. doi: 10.3390/jcm14051540.
4
Proton Beam Therapy for Lung Oligometastatic Recurrence in Patients With Esophageal Cancer.质子束治疗食管癌患者肺部寡转移复发
Cureus. 2023 Dec 11;15(12):e50343. doi: 10.7759/cureus.50343. eCollection 2023 Dec.
5
A nomogram model to individually predict prognosis for esophageal cancer with synchronous pulmonary metastasis.一种用于个体预测伴有同步肺转移的食管癌预后的列线图模型。
Front Oncol. 2023 Jan 4;12:956738. doi: 10.3389/fonc.2022.956738. eCollection 2022.
6
Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer.基于人群的复发性食管或食管胃连接部癌的治疗和结局研究。
Br J Surg. 2022 Nov 22;109(12):1264-1273. doi: 10.1093/bjs/znac290.
7
Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases.立体定向体部放疗治疗肺转移瘤的现状。
Curr Oncol. 2021 Jul 15;28(4):2560-2578. doi: 10.3390/curroncol28040233.